Cargando…
Thalidomide combined with low‐dose short‐term glucocorticoid in the treatment of critical Coronavirus Disease 2019
Autores principales: | Chen, Chengshui, Qi, Feng, Shi, Keqing, Li, Yuping, Li, Ji, Chen, Yongping, Pan, Jingye, Zhou, Tieli, Lin, Xiangyang, Zhang, Jinsan, Luo, Yongde, Li, Xiaokun, Xia, Jinglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403664/ https://www.ncbi.nlm.nih.gov/pubmed/32508009 http://dx.doi.org/10.1002/ctm2.35 |
Ejemplares similares
-
Thalidomide combined with short-term low-dose glucocorticoid therapy for the treatment of severe COVID-19: A case-series study
por: Li, Yuping, et al.
Publicado: (2021) -
Sex- and age-specific clinical and immunological features of coronavirus disease 2019
por: Jin, Shengwei, et al.
Publicado: (2021) -
Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces
por: Dastan, Farzaneh, et al.
Publicado: (2020) -
Increased Glucocorticoid Receptor Alpha Expression and Signaling in Critically Ill Coronavirus Disease 2019 Patients*
por: Vassiliou, Alice G., et al.
Publicado: (2021) -
Thalidomide—Then and Now: Case Report of a Woman With Thalidomide Embryopathy and Review of Current Thalidomide Uses
por: Malik, Sara, et al.
Publicado: (2021)